• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精氨酸琥珀酸合成酶在肝细胞癌患者中的表达。

Expression of argininosuccinate synthetase in patients with hepatocellular carcinoma.

机构信息

Department of Biochemistry and Molecular Biology, School of Basic Medical Science, Peking University, Beijing, China.

出版信息

J Gastroenterol Hepatol. 2013 Feb;28(2):365-8. doi: 10.1111/jgh.12043.

DOI:10.1111/jgh.12043
PMID:23339388
Abstract

BACKGROUND AND AIM

Arginine is a nonessential amino acid for humans and mice because it can be synthesized from citrulline by argininosuccinate synthetase (ASS) and argininosuccinate lyase. Hepatocellular carcinoma (HCC) is believed to be auxotrophic for arginine through the lack of expression of ASS. However, there are also some ASS-positive HCC cells. Therefore, the aim of this article was to study the levels of arginine and the expression of ASS in patients with HCC.

METHODS

Thirty patients with HCC who had undergone HCC surgery were enrolled in the study. Serum arginine levels were determined with an automatic amino acid analyzer. ASS expression was examined by Western blot and immunohistochemistry. Methylation specific polymerase chain reaction and methylation sequencing were performed to detect the methylation of DNA encoding ASS.

RESULTS

There was a decrease of arginine in HCC patients compared with that of healthy control. High expression of ASS was found in the adjacent tissues by Western blot and immunohistochemistry. Little ASS expression was found in most HCC tissues, but there were also some HCC tissues that expressed low levels of ASS. Methylation of the DNA encoding ASS was obviously higher in HCC tissues than that in paired adjacent tissues.

CONCLUSIONS

ASS expression is decreased significantly in HCC tissues. The downregulation of arginine and ASS expression may be a self-defense action of the body against malignant tumors, and the decreased arginine and ASS levels in HCC patients are an advantage for the arginine deiminase treatment.

摘要

背景与目的

精氨酸是人类和小鼠的非必需氨基酸,因为它可以由瓜氨酸通过精氨琥珀酸合成酶(ASS)和精氨琥珀酸裂解酶合成。肝细胞癌(HCC)被认为通过缺乏 ASS 的表达而对精氨酸具有营养缺陷性。然而,也存在一些 ASS 阳性的 HCC 细胞。因此,本文旨在研究 HCC 患者精氨酸水平和 ASS 的表达。

方法

纳入 30 例接受 HCC 手术的 HCC 患者。采用自动氨基酸分析仪测定血清精氨酸水平。通过 Western blot 和免疫组化检测 ASS 表达。采用甲基化特异性聚合酶链反应和甲基化测序检测编码 ASS 的 DNA 的甲基化。

结果

与健康对照组相比,HCC 患者的精氨酸水平降低。Western blot 和免疫组化显示 ASS 在邻近组织中高表达。大多数 HCC 组织中 ASS 表达水平较低,但也有一些 HCC 组织表达低水平的 ASS。与配对的邻近组织相比,HCC 组织中编码 ASS 的 DNA 甲基化明显更高。

结论

ASS 在 HCC 组织中表达明显下调。精氨酸和 ASS 表达的下调可能是机体对恶性肿瘤的一种自我防御反应,HCC 患者精氨酸和 ASS 水平降低是精氨酸脱氨酶治疗的优势。

相似文献

1
Expression of argininosuccinate synthetase in patients with hepatocellular carcinoma.精氨酸琥珀酸合成酶在肝细胞癌患者中的表达。
J Gastroenterol Hepatol. 2013 Feb;28(2):365-8. doi: 10.1111/jgh.12043.
2
Glutamine synthetase as an early marker for hepatocellular carcinoma based on proteomic analysis of resected small hepatocellular carcinomas.基于切除的小肝细胞癌的蛋白质组分析,谷氨酰胺合成酶作为肝细胞癌的早期标志物。
Hepatobiliary Pancreat Dis Int. 2010 Jun;9(3):296-305.
3
The Combination of Arginine Deprivation and 5-Fluorouracil Improves Therapeutic Efficacy in Argininosuccinate Synthetase Negative Hepatocellular Carcinoma.精氨酸剥夺与5-氟尿嘧啶联合应用可提高精氨酸琥珀酸合成酶阴性肝细胞癌的治疗效果。
Int J Mol Sci. 2017 Jun 1;18(6):1175. doi: 10.3390/ijms18061175.
4
Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo.聚乙二醇化精氨酸脱亚氨酶(ADI-SS PEG20,000 mw)在体外和体内均能抑制人黑色素瘤和肝细胞癌。
Cancer Res. 2002 Oct 1;62(19):5443-50.
5
Argininosuccinate synthetase gene is silenced by CpG methylation in children with phenylketonuria.精氨酸琥珀酸合成酶基因在苯丙酮尿症患儿中因 CpG 甲基化而沉默。
Clin Biochem. 2013 Dec;46(18):1793-7. doi: 10.1016/j.clinbiochem.2013.10.028. Epub 2013 Nov 2.
6
Expression of hepatoma-derived growth factor in hepatocellular carcinoma.肝癌衍生生长因子在肝细胞癌中的表达。
Cancer. 2003 Oct 1;98(7):1444-56. doi: 10.1002/cncr.11653.
7
Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma.IRAK3甲基化是肝细胞癌的一种新型预后标志物。
World J Gastroenterol. 2015 Apr 7;21(13):3960-9. doi: 10.3748/wjg.v21.i13.3960.
8
Involvement of RhoA in progression of human hepatocellular carcinoma.RhoA在人类肝细胞癌进展中的作用。
J Gastroenterol Hepatol. 2007 Nov;22(11):1916-20. doi: 10.1111/j.1440-1746.2006.04534.x.
9
Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.N-钙黏蛋白表达降低与肝癌的转移潜能和手术预后不良相关。
J Gastroenterol Hepatol. 2012 Jan;27(1):173-80. doi: 10.1111/j.1440-1746.2011.06847.x.
10
Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search.通过全基因组搜索鉴定BASP1和SRD5A2的新型异常甲基化用于肝细胞癌的早期诊断
Int J Oncol. 2008 Nov;33(5):949-58.

引用本文的文献

1
Development of a Two-Dimensional Liquid Chromatographic Method for Analysis of Urea Cycle Amino Acids.建立一种二维液相色谱法分析尿素循环氨基酸。
Molecules. 2024 Feb 2;29(3):700. doi: 10.3390/molecules29030700.
2
A pan-cancer analysis of the role of argininosuccinate synthase 1 in human tumors.精氨酸琥珀酸合成酶1在人类肿瘤中作用的泛癌分析
Front Oncol. 2023 Nov 20;13:1049147. doi: 10.3389/fonc.2023.1049147. eCollection 2023.
3
PSMD2 contributes to the progression of esophageal squamous cell carcinoma by repressing autophagy.
蛋白酶体26S亚基非ATP酶调节亚基2通过抑制自噬促进食管鳞状细胞癌的进展。
Cell Biosci. 2023 Mar 30;13(1):67. doi: 10.1186/s13578-023-01016-4.
4
Metabolic Profiling Identified a Novel Biomarker Panel for Metabolic Syndrome-Positive Hepatocellular Cancer.代谢组学分析鉴定出代谢综合征阳性肝细胞癌的新型生物标志物谱。
Front Endocrinol (Lausanne). 2022 Jan 26;12:816748. doi: 10.3389/fendo.2021.816748. eCollection 2021.
5
Targeting purine synthesis in ASS1-expressing tumors enhances the response to immune checkpoint inhibitors.针对表达ASS1的肿瘤中的嘌呤合成进行靶向治疗可增强对免疫检查点抑制剂的反应。
Nat Cancer. 2020 Sep;1(9):894-908. doi: 10.1038/s43018-020-0106-7. Epub 2020 Aug 31.
6
PEGylation increases antitumoral activity of arginine deiminase of Streptococcus pyogenes.聚乙二醇化提高了化脓性链球菌精氨酸脱亚氨酶的抗肿瘤活性。
Appl Microbiol Biotechnol. 2022 Jan;106(1):261-271. doi: 10.1007/s00253-021-11728-7. Epub 2021 Dec 15.
7
Phase 1 trial of ADI-PEG 20 and liposomal doxorubicin in patients with metastatic solid tumors.ADI-PEG20 联合多柔比星脂质体治疗转移性实体瘤的Ⅰ期临床试验。
Cancer Med. 2022 Jan;11(2):340-347. doi: 10.1002/cam4.4446. Epub 2021 Nov 28.
8
A phase II clinical study on the efficacy and predictive biomarker of pegylated recombinant arginase on hepatocellular carcinoma.聚乙二醇重组精氨酸酶治疗肝细胞癌的疗效及预测生物标志物的 II 期临床研究。
Invest New Drugs. 2021 Oct;39(5):1375-1382. doi: 10.1007/s10637-021-01111-8. Epub 2021 Apr 15.
9
Argininosuccinate synthase 1 suppresses tumor progression through activation of PERK/eIF2α/ATF4/CHOP axis in hepatocellular carcinoma.精氨酸琥珀酸合成酶 1 通过激活 PERK/eIF2α/ATF4/CHOP 轴抑制肝癌肿瘤进展。
J Exp Clin Cancer Res. 2021 Apr 10;40(1):127. doi: 10.1186/s13046-021-01912-y.
10
Phase 1 trial of ADI-PEG20 plus cisplatin in patients with pretreated metastatic melanoma or other advanced solid malignancies.ADI-PEG20 联合顺铂治疗预处理的转移性黑色素瘤或其他晚期实体瘤的 I 期临床试验。
Br J Cancer. 2021 Apr;124(9):1533-1539. doi: 10.1038/s41416-020-01230-8. Epub 2021 Mar 5.